Geode Capital Management
ODT

Geode Capital Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Geode Capital Management’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-352,814
Closed -$476K – 5077
2021
Q4 		$476K Buy
352,814
+4,381
+1% +$10.4K ﹤0.01% 4074
2021
Q3 		$1.01M Buy
348,433
+62,945
+22% +$209K ﹤0.01% 3668
2021
Q2 		$996K Sell
285,488
-115,589
-29% -$397K ﹤0.01% 3605
2021
Q1 		$1.37M Buy
401,077
+127,824
+47% +$2.42M ﹤0.01% 3427
2020
Q4 		$5.25M Buy
273,253
+73,965
+37% +$1.14M ﹤0.01% 2578
2020
Q3 		$2.68M Buy
199,288
+2,799
+1% +$79.3K ﹤0.01% 2721
2020
Q2 		$8.32M Buy
196,489
+24,785
+14% +$802K ﹤0.01% 2038
2020
Q1 		$4.74M Buy
171,704
+3,718
+2% +$108K ﹤0.01% 2182
2019
Q4 		$5.45M Buy
167,986
+4,342
+3% +$135K ﹤0.01% 2399
2019
Q3 		$4.26M Buy
163,644
+34,576
+27% +$1.16M ﹤0.01% 2472
2019
Q2 		$4.74M Buy
129,068
+22,036
+21% +$528K ﹤0.01% 2433
2019
Q1 		$2.37M Buy
107,032
+13,190
+14% +$231K ﹤0.01% 2756
2018
Q4 		$1.32M Buy
93,842
+21,168
+29% +$330K ﹤0.01% 2987
2018
Q3 		$1.41M Buy
72,674
+2,400
+3% +$48.9K ﹤0.01% 3076
2018
Q2 		$1.55M Buy
70,274
+8,236
+13% +$192K ﹤0.01% 2996
2018
Q1 		$1.31M Buy
+62,038
New +$1.46M ﹤0.01% 2990

Other funds holding ODT

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Geode Capital Management's ODT Position: Q1 2022 in Review

Geode Capital Management sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 352,814 shares — an estimated $476K sold.

Geode Capital Management first reported a position in ODT in Q1 2018 and held it in 16 quarters. The position peaked at $8.32M in Q2 2020. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

  • Geode Capital Management reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Geode Capital Management sold 352,814 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $476K.
  • Geode Capital Management first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2018 and held it in 16 quarters.
  • Geode Capital Management's Odonate Therapeutics, Inc. Common Stock position peaked at $8.32M in Q2 2020.
  • 8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.